Transplant outcomes after de novo donor specific antibody (DSA) development correlate with persistence of DSA
{{output}}
Background: The OuTSMART trial confirmed de novo DSAs were associated with an increased risk of graft loss and rejection. In this post-hoc analysis, outcomes were analysed in 132 patients who had a DSA at the point of randomisati... ...
